Literature DB >> 32152071

Age-Dependent Effects of Type I and Type III IFNs in the Pathogenesis of Bordetella pertussis Infection and Disease.

Jeremy Ardanuy1, Karen Scanlon1, Ciaran Skerry1, Serge Y Fuchs2, Nicholas H Carbonetti3.   

Abstract

Type I and III IFNs play diverse roles in bacterial infections, being protective for some but deleterious for others. Using RNA-sequencing transcriptomics we investigated lung gene expression responses to Bordetella pertussis infection in adult mice, revealing that type I and III IFN pathways may play an important role in promoting inflammatory responses. In B. pertussis-infected mice, lung type I/III IFN responses correlated with increased proinflammatory cytokine expression and with lung inflammatory pathology. In mutant mice with increased type I IFN receptor (IFNAR) signaling, B. pertussis infection exacerbated lung inflammatory pathology, whereas knockout mice with defects in type I IFN signaling had lower levels of lung inflammation than wild-type mice. Curiously, B. pertussis-infected IFNAR1 knockout mice had wild-type levels of lung inflammatory pathology. However, in response to infection these mice had increased levels of type III IFN expression, neutralization of which reduced lung inflammation. In support of this finding, B. pertussis-infected mice with a knockout mutation in the type III IFN receptor (IFNLR1) and double IFNAR1/IFNLR1 knockout mutant mice had reduced lung inflammatory pathology compared with that in wild-type mice, indicating that type III IFN exacerbates lung inflammation. In marked contrast, infant mice did not upregulate type I or III IFNs in response to B. pertussis infection and were protected from lethal infection by increased type I IFN signaling. These results indicate age-dependent effects of type I/III IFN signaling during B. pertussis infection and suggest that these pathways represent targets for therapeutic intervention in pertussis.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32152071      PMCID: PMC7141952          DOI: 10.4049/jimmunol.1900912

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

1.  Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment.

Authors:  Kanstantsin V Katlinski; Jun Gui; Yuliya V Katlinskaya; Angelíca Ortiz; Riddhita Chakraborty; Sabyasachi Bhattacharya; Christopher J Carbone; Daniel P Beiting; Melanie A Girondo; Amy R Peck; Ellen Puré; Priya Chatterji; Anil K Rustgi; J Alan Diehl; Constantinos Koumenis; Hallgeir Rui; Serge Y Fuchs
Journal:  Cancer Cell       Date:  2017-02-13       Impact factor: 31.743

Review 2.  CpG islands and the regulation of transcription.

Authors:  Aimée M Deaton; Adrian Bird
Journal:  Genes Dev       Date:  2011-05-15       Impact factor: 11.361

3.  Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A.

Authors:  Francis J Martin; Marisa I Gomez; Dawn M Wetzel; Guido Memmi; Maghnus O'Seaghdha; Grace Soong; Christian Schindler; Alice Prince
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

4.  Type I IFN protects permissive macrophages from Legionella pneumophila infection through an IFN-gamma-independent pathway.

Authors:  Giovanna Schiavoni; Claudia Mauri; Davide Carlei; Filippo Belardelli; Maddalena Castellani Pastoris; Enrico Proietti
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

5.  Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production.

Authors:  Alessandro Michelucci; Thekla Cordes; Jenny Ghelfi; Arnaud Pailot; Norbert Reiling; Oliver Goldmann; Tina Binz; André Wegner; Aravind Tallam; Antonio Rausell; Manuel Buttini; Carole L Linster; Eva Medina; Rudi Balling; Karsten Hiller
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

6.  Sphingosine-1-phosphate Receptor Agonism Reduces Bordetella pertussis-mediated Lung Pathology.

Authors:  Ciaran Skerry; Karen Scanlon; Hugh Rosen; Nicholas H Carbonetti
Journal:  J Infect Dis       Date:  2014-12-23       Impact factor: 5.226

Review 7.  Antibiotics for whooping cough (pertussis).

Authors:  S Altunaiji; R Kukuruzovic; N Curtis; J Massie
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

8.  Type III interferon is a critical regulator of innate antifungal immunity.

Authors:  Vanessa Espinosa; Orchi Dutta; Constance McElrath; Peicheng Du; Yun-Juan Chang; Bryan Cicciarelli; Amy Pitler; Ian Whitehead; Joshua J Obar; Joan E Durbin; Sergei V Kotenko; Amariliz Rivera
Journal:  Sci Immunol       Date:  2017-10-06

9.  Lung response to Bordetella pertussis infection in mice identified by gene-expression profiling.

Authors:  Sander Banus; Jeroen Pennings; Rob Vandebriel; Piet Wester; Timo Breit; Frits Mooi; Barbara Hoebee; Tjeerd Kimman
Journal:  Immunogenetics       Date:  2007-05-09       Impact factor: 2.846

10.  Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells.

Authors:  Xiaoming Zhang; Edith Deriaud; Xinan Jiao; Deborah Braun; Claude Leclerc; Richard Lo-Man
Journal:  J Exp Med       Date:  2007-05-07       Impact factor: 14.307

View more
  4 in total

Review 1.  Functions of IFNλs in Anti-Bacterial Immunity at Mucosal Barriers.

Authors:  Noémie Alphonse; Ruth E Dickenson; Abrar Alrehaili; Charlotte Odendall
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

2.  Lack of evidence supporting a role of IFN-β and TGF-β in differential polarization of Bordetella pertussis specific-T cell responses.

Authors:  Ricardo da Silva Antunes; Lorenzo G Quiambao; Ferran Soldevila; Aaron Sutherland; Bjoern Peters; Alessandro Sette
Journal:  Cytokine       Date:  2020-09-29       Impact factor: 3.861

3.  Naturally circulating pertactin-deficient Bordetella pertussis strains induce distinct gene expression and inflammatory signatures in human dendritic cells.

Authors:  Michiel M Kroes; Alberto Miranda-Bedate; Elise S Hovingh; Ronald Jacobi; Corrie Schot; Elder Pupo; René H M Raeven; Arno A J van der Ark; Jos P M van Putten; Jelle de Wit; Rob Mariman; Elena Pinelli
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

4.  Distinct molecular phenotypes involving several human diseases are induced by IFN-λ3 and IFN-λ4 in monocyte-derived macrophages.

Authors:  Manjarika De; Anand Bhushan; William S Grubbe; Subhajit Roy; Juan L Mendoza; Sreedhar Chinnaswamy
Journal:  Genes Immun       Date:  2022-02-03       Impact factor: 4.248

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.